Physician profile
Imran Baig
NPI 1679567838
$7,854.31
in general payments reported to CMS, 2019-2025
19 companies · $820 in 2025
The $820 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.59 · 2020: $56.85 · 2021: $5,033 · 2022: $266 · 2023: $679 · 2024: $918 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,765 · Travel and Lodging: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.00 |
| Travel and Lodging | $651.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,060.24 | 2021-2025 | Navitor, Amplatzer Amulet, Confirm Rx |
| Smith+Nephew, INC. | $901.46 | 2022-2025 | Grafix, Collagenase Santyl, Regranex |
| Edwards Lifesciences Corporation | $290.71 | 2021-2022 | |
| Biotronik INC. | $255.53 | 2021-2025 | Orsiro Mission |
| Astrazeneca Pharmaceuticals Lp | $254.75 | 2022-2023 | Farxiga |
| Medtronic, INC. | $236.94 | 2023-2025 | Onyx Frontier, Corevalve Evolut R, Ffrangio |
| Glaxosmithkline, LLC. | $202.56 | 2019-2023 | Bexsero |
| Abiomed | $157.70 | 2021 | |
| Cranial Technologies, INC | $153.91 | 2021-2025 | Doc Band |
| Pfizer INC. | $124.98 | 2025 | |
| Merck Sharp & Dohme LLC | $53.43 | 2019-2025 | Vaxelis, Gardasil 9, Enflonsia |
| Baxter Healthcare | $37.36 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Eisai INC. | $22.97 | 2019 | |
| Alcon Vision LLC | $21.00 | 2022 | |
| Lnhc, INC | $18.81 | 2025 | Zelsuvmi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17.28 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $17.05 | 2025 | Neffy |
| Janssen Pharmaceuticals, INC | $15.69 | 2019 | |
| Lilly USA, LLC | $11.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Baig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.